Farther Finance Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.39M Buy
58,478
+1,873
+3% +$247K 0.06% 290
2026
Q1
$7.94M Sell
56,605
-207
-0.4% -$29K 0.08% 237
2025
Q4
$6.97M Buy
56,812
+17,325
+44% +$2.11M 0.07% 240
2025
Q3
$4.38M Sell
39,487
-2,223
-5% -$253K 0.07% 247
2025
Q2
$4.62M Buy
41,710
+4,223
+11% +$449K 0.09% 205
2025
Q1
$4.17M Buy
37,487
+18,194
+94% +$1.88M 0.11% 182
2024
Q4
$1.78M Buy
19,293
+1,518
+9% +$137K 0.06% 237
2024
Q3
$1.49M Buy
17,775
+547
+3% +$41.7K 0.06% 253
2024
Q2
$1.18M Buy
17,228
+79
+0.5% +$5.27K 0.06% 266
2024
Q1
$1.25M Sell
17,149
-7,980
-32% -$614K 0.08% 219
2023
Q4
$2.04M Buy
25,129
+15,618
+164% +$1.22M 0.15% 130
2023
Q3
$713K Buy
9,511
+2,982
+46% +$229K 0.11% 157
2023
Q2
$503K Buy
6,529
+199
+3% +$15.9K 0.11% 160
2023
Q1
$525K Buy
6,330
+5,010
+380% +$415K 0.15% 124
2022
Q4
$113K Buy
+1,320
New +$105K 0.04% 299

Other funds holding GILD

Farther Finance Advisors's GILD Position: Q2 2026 in Review

Farther Finance Advisors increased its Gilead Sciences (GILD) stake by 3.3% in Q2 2026, buying an estimated $247K and bringing the position to 58,478 shares worth $7.39M. The position accounts for 0.06% of the portfolio, ranked #290.

Farther Finance Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.94M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Farther Finance Advisors held 58,478 shares of Gilead Sciences worth $7.39M as of Q2 2026.
  • Farther Finance Advisors bought 1,873 Gilead Sciences shares in Q2 2026, an estimated $247K.
  • Gilead Sciences made up 0.06% of Farther Finance Advisors's portfolio in Q2 2026, its #290 holding.
  • Farther Finance Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Gilead Sciences position peaked at $7.94M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.